Middle meningeal artery embolization versus standard of care for chronic subdural hematoma: Meta-analysis of randomized controlled trials.

ABSTRACT: BackgroundThe safety and efficacy of the middle meningeal artery embolization (MMAE) in patients with non-acute or chronic subdural hematoma (cSDH) has significant reporting within recent literature, however, mainly in the form of observational data.MethodsWe conducted a systematic review and meta-analysis including all available randomized clinical trials (RCTs) that compared MMAE in addition to standard of care (SOC) versus SOC alone for cSDH. The primary outcome was the rate of recurrence and reoperation. Secondary outcomes included serious adverse events (SAEs), mortality rate, independent ambulation (modified Rankin Scale (mRS) score 0-3), and changes in hematoma characteristics at 90 days. The fixed-effect or random-effects model was used based on the significancy of the heter

SUBMITTER: Mortezaei A 

PROVIDER: S-EPMC12540358 | biostudies-literature | 2025 Oct

REPOSITORIES: biostudies-literature